US Stock MarketDetailed Quotes

CDLA Candela Medical

Watchlist
  • 0.000
  • 0.0000.00%
Close Jan 8 09:30 ET
0Market Cap0.00P/E (TTM)

Candela Medical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Total revenue
-17.48%321.65M
389.77M
Operating revenue
-17.48%321.65M
--389.77M
Cost of revenue
-17.21%182.57M
220.52M
Gross profit
-17.83%139.08M
169.25M
Operating expense
-17.46%159.12M
192.77M
Selling and administrative expenses
-18.35%135.59M
--166.07M
-Selling and marketing expense
-30.69%85.74M
--123.7M
-General and administrative expense
17.66%49.85M
--42.37M
Research and development costs
-11.89%23.53M
--26.7M
Operating profit
14.79%-20.04M
-23.52M
Net non-operating interest income expense
-365.02%-12.43M
-2.67M
Non-operating interest expense
365.02%12.43M
--2.67M
Other net income (expense)
-672.66%-2.97M
-384K
Gain on sale of security
-760.24%-3.53M
---410K
Special income (charges)
38.36%-810K
---1.31M
-Gain on sale of property,plant,equipment
38.36%-810K
---1.31M
Other non- operating income (expenses)
2.24%1.37M
--1.34M
Income before tax
-33.34%-35.44M
-26.58M
Income tax
1.70%8.45M
8.31M
Net income
-25.80%-43.89M
-34.89M
Net income continuous Operations
-25.80%-43.89M
---34.89M
Minority interest income
Net income attributable to the parent company
-25.80%-43.89M
-34.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-25.80%-43.89M
-34.89M
Basic earnings per share
-25.74%-0.449
-0.3571
Diluted earnings per share
-25.74%-0.449
-0.3571
Dividend per share
Currency Unit
USD
USD
Audit Opinions
Unqualified Opinion
--
(FY)Dec 31, 2020(FY)Dec 31, 2019
Total revenue -17.48%321.65M389.77M
Operating revenue -17.48%321.65M--389.77M
Cost of revenue -17.21%182.57M220.52M
Gross profit -17.83%139.08M169.25M
Operating expense -17.46%159.12M192.77M
Selling and administrative expenses -18.35%135.59M--166.07M
-Selling and marketing expense -30.69%85.74M--123.7M
-General and administrative expense 17.66%49.85M--42.37M
Research and development costs -11.89%23.53M--26.7M
Operating profit 14.79%-20.04M-23.52M
Net non-operating interest income expense -365.02%-12.43M-2.67M
Non-operating interest expense 365.02%12.43M--2.67M
Other net income (expense) -672.66%-2.97M-384K
Gain on sale of security -760.24%-3.53M---410K
Special income (charges) 38.36%-810K---1.31M
-Gain on sale of property,plant,equipment 38.36%-810K---1.31M
Other non- operating income (expenses) 2.24%1.37M--1.34M
Income before tax -33.34%-35.44M-26.58M
Income tax 1.70%8.45M8.31M
Net income -25.80%-43.89M-34.89M
Net income continuous Operations -25.80%-43.89M---34.89M
Minority interest income
Net income attributable to the parent company -25.80%-43.89M-34.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -25.80%-43.89M-34.89M
Basic earnings per share -25.74%-0.449-0.3571
Diluted earnings per share -25.74%-0.449-0.3571
Dividend per share
Currency Unit USDUSD
Audit Opinions Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.